Design, Synthesis, and In Vitro Evaluation of Benzofuro[3,2-
c]Quinoline Derivatives as Potential Antileukemia Agents.
Molecules 2020;
25:molecules25010203. [PMID:
31947824 PMCID:
PMC6983037 DOI:
10.3390/molecules25010203]
[Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2019] [Revised: 12/30/2019] [Accepted: 01/01/2020] [Indexed: 11/16/2022] Open
Abstract
Herein, we design and synthesize an array of benzofuro[3,2-c]quinolines starting from 3-(2-methoxyphenyl)quinolin-4(1H)ones via a sequential chlorination/demethylation, intramolecular cyclization pathway. This sequential transformation was efficient, conducted under metal-free and mild reaction conditions, and yielded corresponding benzofuro[3,2-c]quinolines in high yields. In vitro biological evaluation indicated that such type of compounds showed excellent antileukemia activity and selectivity, and therefore may offer a promising hit compound for developing antileukemia compounds.
Collapse